The Cost Effectiveness of Immunoglobulin vs. Hematopoietic Stem Cell Transplantation for CIDP

Background: Intravenous immunoglobulin (IVIG) is effective as standard first line therapy for chronic inflammatory demyelinating polyradiculoneuropathy (CIDP), but some patients remain dependent on its long-term use. Recently, we have reported that autologous non-myeloablative hematopoietic stem cel...

Descripción completa

Detalles Bibliográficos
Autores principales: Burt, Richard K., Tappenden, Paul, Balabanov, Roumen, Han, Xiaoqiang, Quigley, Kathleen, Snowden, John A., Sharrack, Basil
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Neurology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8019941/
https://www.ncbi.nlm.nih.gov/pubmed/33828522
http://dx.doi.org/10.3389/fneur.2021.645263

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8019941/
https://www.ncbi.nlm.nih.gov/pubmed/33828522
http://dx.doi.org/10.3389/fneur.2021.645263

Ejemplares similares